About Oncophenomics
Oncophenomics is a Healthcare company based in Hyderabad (India) founded in 2016 by Mike Raghavan and Shibichakravarthy Kannan. Genomic tests are developed for personalized cancer medicine. Oncophenomics has raised $606.18 thousand across 5 funding rounds from investors including Pfizer, Mumbai Angels and T-Hub. Oncophenomics was last valued at $1.51 million in March 2018. Its chief executive, as recorded, is Shibichakravarthy Kannan. Its focus areas include Life Sciences, Genomics, Applied Genomics and Clinical Genomics. Its legal entity in India is Theranosis Life Sciences Private Limited (U85191TG2016PTC103127).
Company details
Oncophenomics was founded in 2016 in Hyderabad, India, within the biotechnology sector. Genomic tests are developed to enable personalized medicine for cancer patients. The platform features Fathom Dx, a liquid biopsy test that integrates genomic and epigenomic biomarkers across the entire genome. This approach supports cancer diagnostics and informs clinical outcomes based on comprehensive biomarker analysis.
- Headquarters Hyderabad, India
- Founders Mike Raghavan, Shibichakravarthy Kannan
- Stage Minicorn
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website oncophenomics.com
- Social LinkedIn
- Legal Name Theranosis Life Sciences Private Limited
- Date of Incorporation 05 Feb, 2016
- Jurisdiction Habsiguda, Telangana, India
- Total Equity Funding$606.18K (USD)
in 5 rounds
- Latest Funding Round$81.51K (USD), Grant
Sep 2022
- InvestorsPfizer
& 46 more
Associated legal entities of Oncophenomics
Oncophenomics operates through Theranosis Life Sciences Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2018) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Theranosis Life Sciences Private Limited CIN U85191TG2016PTC103127 | Active | 05 Feb 2016 | Habsiguda, Telangana | 2 | View details |
Funding Insights of Oncophenomics
Oncophenomics has successfully raised a total of $606.18K across 5 strategic funding rounds. The most recent funding activity was a Grant round of $81.51 thousand completed in September 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $606,184
- Total Rounds 5
- Last Round Grant — $81,511
- First Round $29,042
(Feb 2016)
- Investors Count 47
All 5 funding rounds of Oncophenomics with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Sep 2022 | $81,511 | Grant | – | Pfizer | |
| Apr 2019 | Seed | – | T-Hub | – | |
| Mar 2018 | $546,082 | Seed | $1.51M | Omphalos Ventures | |
| May 2017 | $31,060 | Seed | $527,688 | CIIE | – |
| Feb 2016 | $29,042 | Seed | $••••• | Anil Yamani, Xseed Partners |
| Date | Valuation | Stage |
|---|---|---|
| Mar 2018 | $1.51M | •••••••• |
Last known valuation $1.51M (Mar 2018). 47 investors in total: 23 institutional and 24 angel.
Investors in Oncophenomics
Oncophenomics has secured backing from 47 investors, including institutional, venture fund, and angel investors. Prominent investors backing the company include Pfizer, Mumbai Angels and T-Hub.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Sustainable startups are supported via innovation curation and venture funding. | socialalpha.org | Bengaluru, India | ||
Innovation hub connecting startups, corporates, and partners in technology and ecosystem development. | 2015 | t-hub.co | Hyderabad, India | |
Early-stage venture investments are facilitated by Mumbai Angels network. | 2006 | mumbaiangels.com | Mumbai, India | |
Venture capital investments are directed toward fintech and diverse sectors. | Kolkata, India | |||
Venture capital firm focused on seed-stage investments | Kolkata, India | |||
Venture capital investments are managed by the single family office. | Mumbai, India | |||
Venture capital firm focused on multiple sectors | ||||
Venture capital firm providing investments and support to start-ups in various sectors. | sharpventures.in | Hyderabad, India | ||
Incubation and management consulting services are provided for start-ups and emerging businesses across various sectors. | 2011 | purpleventures.co.in | Mumbai, India | |
Early-stage investments are made by Omphalos Ventures in US firms. | omphalosventures.net | Shakopee, United States |
Investor details for Oncophenomics
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Board of directors of Theranosis Life Sciences Private Limited (Oncophenomics)
Theranosis Life Sciences Private Limited is the primary company behind Oncophenomics. The board of Theranosis Life Sciences Private Limited currently have 2 directors; the longest-serving is Shibichakravarthy Kannan, appointed in 2016. 2 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Shibichakravarthy Kannan DIN 07213132 | Director | 05 Feb 2016 | 10 yrs 8 mo | Theranosis Life Sciences Private Limited |
| Vennila DIN 08018858 | Director | 11 Dec 2017 | 8 yrs 10 mo | Theranosis Life Sciences Private Limited |
People of Oncophenomics
2 people are tracked at Oncophenomics (2 in leadership).
| Name | Role | Group |
|---|---|---|
| Co-Founder | Leadership | |
| Co-Founder & CEO | Leadership |
Complete people profiles for Oncophenomics
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Oncophenomics
4 dated milestones of Oncophenomics across 6 years, from founding to its latest funding, stage changes and deals.
- Founded Oncophenomics is founded.
- Funding First funding round of $29K.
- Milestone Reaches Minicorn status.
- Funding Latest funding round, Grant, of $82K.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Oncophenomics
Complete news archive for Oncophenomics
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Oncophenomics
Oncophenomics was founded in 2016.
Oncophenomics is headquartered in Hyderabad, India. It is registered at Hyderabad, Telangana, India.
Shibichakravarthy Kannan is the CEO of Oncophenomics, as recorded in our data. They have also founded this company.
Oncophenomics is a funded company, having raised a total of $606.18K across 5 funding rounds to date. The company's 1st funding round was a Seed of $29.04K, raised on Feb 2016.
Oncophenomics was founded in 2016 in Hyderabad, India, within the biotechnology sector. Genomic tests are developed to enable personalized medicine for cancer patients. The platform features Fathom Dx, a liquid biopsy test that integrates genomic and epigenomic biomarkers across the entire genome. This approach supports cancer diagnostics and informs clinical outcomes based on comprehensive biomarker analysis.
Oncophenomics has 47 investors. Key investors include Pfizer, Mumbai Angels, T-Hub, 50k Ventures, and Xseed Partners.
The valuation of Oncophenomics is $1.51M as of Mar 2018.
Oncophenomics operates through Theranosis Life Sciences Private Limited.
The legal entities of Oncophenomics currently have 2 directors, including Shibichakravarthy Kannan, Vennila.